PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
John Q Trojanowski Selected Research
Dementia (Dementias)
07/2008
Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
01/2008
Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
01/2008
Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease.
10/2007
TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions.
10/2007
TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis.
07/2007
TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease.
07/2007
TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.
05/2007
Absence of heterogeneous nuclear ribonucleoproteins and survival motor neuron protein in TDP-43 positive inclusions in frontotemporal lobar degeneration.
04/2007
Biochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual.
03/2007
TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions.
10/2006
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
10/2006
Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.
03/2004
17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.
03/2004
Assessment of pathological tau proteins in frontotemporal dementias: qualitative and quantitative approaches.
12/2003
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
05/2003
Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study.
05/2002
Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam.
Articles by Research Topic
Disease
17
Dementia (Dementias)
07/2008 - 05/2002
8
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
07/2008 - 03/2004
8
Alzheimer Disease (Alzheimer's Disease)
06/2008 - 10/2002
7
Tauopathies
06/2008 - 06/2002
7
Brain Injuries (Brain Injury)
12/2007 - 04/2003
6
Parkinson Disease (Parkinson's Disease)
05/2008 - 02/2002
5
Amyloidosis
01/2008 - 07/2002
4
Neurodegenerative Diseases (Neurodegenerative Disease)
12/2007 - 03/2004
2
Parkinsonian Disorders (Parkinsonism)
01/2008 - 05/2002
2
Motor Neuron Disease (Primary Lateral Sclerosis)
01/2008 - 07/2007
2
Multiple System Atrophy
03/2005 - 03/2004
2
Cytomegalovirus Infections (Inclusion Disease)
09/2004 - 06/2004
2
Pick Disease of the Brain (Pick's Disease)
10/2002 - 06/2002
1
Tremor (Tremors)
05/2006
1
Renal Cell Carcinoma (Grawitz Tumor)
05/2005
1
Hemangioblastoma
05/2005
1
Medulloblastoma
08/2003
1
Neoplasms (Cancer)
08/2003
1
Macular Degeneration (Age-Related Maculopathy)
05/2003
1
Brain Diseases (Brain Disorder)
07/2002
1
Movement Disorders (Movement Disorder)
05/2002
1
Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
05/2002
1
Stroke (Strokes)
04/2002
Drug/Important Bio-Agent (IBA)
12
protein TDP-43
IBA
05/2008 - 10/2006
10
alpha-Synuclein
IBA
10/2006 - 02/2002
5
tau Proteins (tau Protein)
IBA
04/2007 - 10/2002
5
Amyloid (Amyloid Fibrils)
IBA
08/2004 - 05/2003
4
Ubiquitin
IBA
10/2007 - 10/2006
2
alpha-internexin
IBA
09/2004 - 06/2004
2
Vitamin E
FDA Link
08/2004 - 02/2004
2
Biological Markers (Surrogate Marker)
IBA
12/2003 - 07/2003
1
DNA (Deoxyribonucleic Acid)
IBA
07/2008
1
DNA-Binding Proteins (DNA Binding Protein)
IBA
06/2008
1
Dopamine (Intropin)
FDA Link
Generic
05/2008
1
Proteins (Proteins, Gene)
IBA
12/2007
1
Paclitaxel (Taxol)
FDA Link
Generic
07/2007
1
Carbamates
IBA
07/2007
1
Heterogeneous-Nuclear Ribonucleoproteins (Informatin)
IBA
05/2007
1
Monoclonal Antibodies
IBA
10/2006
1
pantothenate kinase
IBA
05/2006
1
Iron
IBA
05/2006
1
Lithium
IBA
12/2005
1
Antigens
IBA
05/2005
1
Brain-Derived Neurotrophic Factor (BDNF)
IBA
04/2005
1
Nerve Growth Factor (NGF)
IBA
12/2004
1
NF-kappa B (NF-kB)
IBA
12/2004
1
Indomethacin (Indometacin)
FDA Link
Generic
12/2004
1
Caspase 3 (Caspase-3)
IBA
08/2004
1
Amyloid Precursor Protein Secretases (beta-Secretase)
IBA
08/2004
1
Presenilin-1
IBA
08/2004
1
alpha-Tocopherol
FDA Link
07/2004
1
Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)
IBA
05/2004
1
Levodopa (L Dopa)
FDA Link
Generic
03/2004
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
01/2004
1
Crystallins (Crystallin)
IBA
01/2004
1
gamma-Synuclein (Persyn)
IBA
08/2003
1
Rotenone
IBA
01/2003
1
Aluminum
IBA
07/2002
1
Protein Isoforms (Isoforms)
IBA
06/2002
1
Carbon Monoxide
IBA
05/2002
Therapy/Procedure
2
Transplantation (Transplant Recipients)
12/2005 - 11/2004
2
Transplants (Transplant)
04/2003 - 04/2002
1
Deep Brain Stimulation
03/2004